Who are Abata Therapeutics's investors?

Abata Therapeutics's investors include Third Rock Ventures, Lightspeed VP, Invus, Samsara BioCapital, JDRF T1D Fund.

When was Abata Therapeutics founded?

Abata Therapeutics was founded in 2021.

Where is Abata Therapeutics headquartered?

Abata Therapeutics is headquartered in Watertown, Massachusetts, United States.

What industry is Abata Therapeutics in?

Abata Therapeutics operates in Biotech, Immunology, Therapeutics.

How many employees does Abata Therapeutics have?

Abata Therapeutics has 11-50 employees.

Abata Therapeutics

Closed

Watertown, United States · Founded 2021

Biotech

Immunology

Therapeutics

Headquarters: Watertown, Massachusetts
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: abata.com
Last Round: Series AJun 2021
Rounds: 1

About

Abata Therapeutics was a clinical-stage biotech company dedicated to developing engineered regulatory T cell (Treg) therapies for severe autoimmune and inflammatory diseases, with lead programs in progressive multiple sclerosis and type 1 diabetes. Founded in 2021 by Third Rock Ventures, the company shut down in 2025 after being unable to secure additional funding.

Summary

Abata Therapeutics is a Biotech company based in Watertown, United States, founded in 2021. Its most recent funding was a Series A round in Jun 2021. Investors include Third Rock Ventures, Lightspeed VP and Invus.